Bill

Bill > S4294


NJ S4294

NJ S4294
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.


summary

Introduced
03/24/2025
In Committee
12/08/2025
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

AI Summary

This bill requires the New Jersey Medicaid program to provide coverage for ovulation enhancing drugs and related medical services for individuals aged 21-44 who are experiencing infertility. The bill defines infertility as the inability to establish a clinical pregnancy after 12 months of regular, unprotected sexual intercourse for those 21-34 years old, or after six months for those 35-44 years old. The coverage is limited to three treatment cycles per lifetime and includes specific medical services such as office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing. Importantly, the bill explicitly states that the definition of infertility should not be used to deny or delay treatment based on an individual's relationship status or sexual orientation. The bill requires the Commissioner of Human Services to apply for necessary state plan amendments or waivers to implement the coverage and secure federal financial participation, and mandates the adoption of regulations to put the new provisions into effect. The coverage will become effective on the first day of the fourth month following the bill's enactment.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (3)

Last Action

Referred to Senate Budget and Appropriations Committee (on 12/08/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...